SDP — Kappa And Lambda Immunoglobulin Light Chain In Situ Hybridization Mrna Probe Detection Kit Class II

FDA Device Classification

FDA product code SDP covers "Kappa And Lambda Immunoglobulin Light Chain In Situ Hybridization Mrna Probe Detection Kit", a Class II medical device regulated under 21 CFR 864.1861. Submissions are reviewed by the Hematology panel. At least 1 recent 510(k) clearance has been granted under this product code.

Classification Details

Product Code
SDP
Device Class
Class II
Regulation Number
864.1861
Submission Type
Review Panel
MG
Medical Specialty
Hematology
Implant
No

Definition

A kappa and lambda immunoglobulin light chain in situ hybridization (ISH) mRNA probe is intended as an aid in the identification of hematolymphoid neoplasms using in situ hybridization. A Kappa and Lambda ISH mRNA probe cocktail is indicated for use when a hematolymphoid biopsy (e.g., bone marrow, lymphoid tissue) yields inconclusive results. The assay is intended as an aid in the diagnosis of mature B-cell lymphomas and plasma cell neoplasms

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
DEN240025ventana medical systemsVENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001)December 5, 2024